CB2受体调节对儿科炎性肠病中巨细胞极化的影响
Mara Creoli1, Alessandra Di Paola1,2, Antonietta Tarallo3
1Department of Woman, Child and General and Specialist Surgery, University of Campania "Luigi Vanvitelli", Via Luigi de Crecchio 2, 80138 Naples, Italy.
International journal of molecular sciences
|May 7, 2025
概括
在患有炎症性肠病 (IBD) 的儿童中,大麻素受体2型 (CB2) 刺激恢复了铁代谢,促进了抗炎性巨细胞的两极分化,并改善了肠道屏障功能,这表明CB2是治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 巨细胞是肠道平衡的关键,具有M1 (促炎) 和M2 (抗炎) 类型的表型.
- 大麻素受体2型 (CB2) 参与免疫调节,是炎症性肠病 (IBD) 的潜在治疗点.
- 患有IBD的儿童表现出改变的巨细胞表型和肠道功能受损.
研究的目的:
- 在儿科IBD患者中调查循环巨细胞表型和CB2表达.
- 评估CB2刺激在调节巨细胞极化,铁代谢和IBD肠道屏障功能的作用.
- 评估CB2作为IBD的潜在治疗点.
主要方法:
- 从患有性结肠炎 (UC),克罗恩病 (CD) 和健康对照的儿童中分离出巨细胞.
- 细胞接受了CB2激动剂 (JWH-133) 和逆激动剂 (AM630) 的治疗.
- 使用体外模型评估CB2表达,巨分极 (M1/M2标记物),铁代谢 (IL-6,肝素,FPN-1,铁度),炎症 (细胞因子) 和肠道屏障功能.
主要成果:
- IBD巨体显示CB2表达减少,M1标志物增加,M2标志物减少,促炎性细胞因子升高,铁代谢发生变化 ([Fe3+]增加,肝素,DMT1;FPN-1减少).
- CB2刺激逆转了这些变化,促进了M2极化,恢复了铁代谢,并增强了肠道屏障功能.
- CB2反向激动症没有显示显著的影响 (隐含).
结论:
- 在儿科IBD中,CB2受体信号受损,导致巨细胞功能障碍和改变铁代谢.
- 通过恢复巨细胞平衡,使铁平衡正常化和修复肠道屏障,CB2刺激为IBD提供了一个有前途的治疗策略.
- 准CB2可能是治疗儿童炎症性肠病的新方法.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
101
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
101
Inflammatory Response
1.6K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.6K
Inflammatory Bowel Disease II: Crohn's Disease
129
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
129
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
86
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
86


